百奥赛图-B（02315）今日盘中大涨6.04%，引发市场关注。公司股价的强劲表现与其近期发布的亮眼中期业绩密切相关。
根据公司发布的2025年中期报告，百奥赛图-B上半年实现营收6.21亿元，同比大幅增长51.5%。更值得注意的是，公司净利润不仅实现扭亏为盈，还超过了去年全年水平，达到4800万元。同时，公司净现金流全面转正，达3330多万元，展现出强劲的自我造血能力。
百奥赛图-B的优异业绩主要得益于其独特的"创新动物模型+抗体分子转让"双轮驱动商业模式。公司在创新药早期研发和评价领域建立了差异化的竞争壁垒，其两大核心业务均实现高速增长。此外，公司还积极布局海外市场，不断强化技术优势和专利保护，进一步巩固了其在行业中的领先地位。随着公司业务模式得到市场验证，投资者对其长期发展前景的信心明显增强。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.